Panobacumab

Panobacumab (KBPA101) is a fully human IgM/κ monoclonal antibody generated by immortalizing human B lymphocytes against the LPS O polysaccharide of serotype O11 of P. aeruginosa[1].

Product Specifications

CAS Number

[885053-97-4]

Product Name Alternative

KBPA101

UNSPSC

12352203

Target

Bacterial

Type

Inhibitory Antibodies

Related Pathways

Anti-infection

Applications

COVID-19-immunoregulation

Field of Research

Infection

Assay Protocol

https://www.medchemexpress.com/panobacumab.html

Purity

98.24

Solubility

10 mM in DMSO

Smiles

[Panobacumab]

Molecular Weight

(172.5 kDa)

References & Citations

[1]Horn MP, et al. Preclinical in vitro and in vivo characterization of the fully human monoclonal IgM antibody KBPA101 specific for Pseudomonas aeruginosa serotype IATS-O11. Antimicrob Agents Chemother. 2010 Jun;54 (6) :2338-44.